Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01706432 · ClinicalTrials.gov registry record

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

A clinical trial of Liver Metastases and Male Breast Cancer, sponsored by University of Chicago.

Completed
Registry status
4
Enrollment target
1
Study location

NCT01706432 is a study of Liver Metastases and Male Breast Cancer that has completed, run by University of Chicago. The registered enrollment target is 4 participants, below the 68-participant average among 27 other Liver Metastases trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01706432, a study of Liver Metastases and Male Breast Cancer, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
4 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies new ways to monitor the impact of hypofractionated image guided radiation therapy in treating patients with stage IV breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.

Conditions Studied

Liver Metastases Male Breast Cancer Lobular Breast Carcinoma in Situ Invasive Ductal Breast Carcinoma Lung Metastases Invasive Lobular Breast Carcinoma Central Nervous System Metastases Invasive Ductal Breast Carcinoma With Predominant Intraductal Component Invasive Lobular Breast Carcinoma With Predominant in Situ Component Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate

Interventions

  • OTHER laboratory biomarker analysis
  • RADIATION stereotactic radiosurgery
  • RADIATION hyperfractionated radiation therapy

Study Locations (1)

Illinois

  • University of Chicago - North Chicago

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2009-06-15
Est. Completion 2024-01-22

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01706432

The ClinicalTrials.gov registry entry for NCT01706432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 68-participant average among 27 other Liver Metastases trials with a reported enrollment target (94% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Liver Metastases appearing as the primary indexed condition, and to 3 interventions - of which laboratory biomarker analysis is the first listed.

NCT01706432 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01706432 about?

NCT01706432 is a clinical study titled "Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer". This pilot clinical trial studies new ways to monitor the impact of hypofractionated image guided radiation therapy in treating patients with stage IV breast cancer. Radiation therapy uses high energy x rays to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells.

What is the current status of trial NCT01706432?

This trial is currently completed. The enrollment target is 4 participants. The study started on 2009-06-15. Estimated completion is 2024-01-22.

What conditions does trial NCT01706432 study?

This clinical trial studies the following conditions: Liver Metastases, Male Breast Cancer, Lobular Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma, Lung Metastases.

What interventions are being tested in trial NCT01706432?

The interventions under investigation include: laboratory biomarker analysis (OTHER), stereotactic radiosurgery (RADIATION), hyperfractionated radiation therapy (RADIATION).

Who is sponsoring clinical trial NCT01706432?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01706432 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Liver Metastases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Liver Metastases

All registered trials for this condition

Male Breast Cancer

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.